20 Stocks Moving in Thursday's Pre-Market Session

Author: Lisa Levin | January 13, 2022 07:33am

Gainers

• BTCS Inc. (NASDAQ:BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday.
• Adagio Therapeutics, Inc. (NASDAQ:ADGI) rose 22.8% to $7.16 in pre-market trading. Adagio Therapeutics highlighted that 'recent publications by several independent laboratories show ADG20 has neutralizing activity with potency comparable to other antibodies that retain activity against omicron.'
• Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 13.4% to $0.4809 in pre-market trading. The company recently highlighted HRSA and Department of Labor guidance related to contraceptive access, saying it could expand access to Phexxi.
• Puma Biotechnology, Inc. (NASDAQ:PBYI) shares rose 9.9% to $2.88 in pre-market trading after the company announced its NERLYNX was included in two important NCCN Clinical Practice Guideline updates for the treatment of breast cancer.
• Volt Information Sciences, Inc. (NYSE:VOLT) rose 9.6% to $3.55 in pre-market trading after the company reported better-than-expected Q4 results.
• KB Home (NYSE:KBH) rose 6.9% to $45.32 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter on Wednesday.
• Lion Group Holding Ltd. (NASDAQ:LGHL) rose 6.9% to $1.40 in pre-market trading.
• ReNew Energy Global plc (NASDAQ:RNW) rose 6.9% to $7.60 in pre-market trading. ReNew recently raised $400 million by issuing Green Bonds.
• Just Eat Takeaway.com N.V. (NASDAQ:GRUB) rose 6.7% to $10.87 in pre-market trading after gaining around 4% on Wednesday.
• Exela Technologies, Inc. (NASDAQ:XELA) rose 5.9% to $0.6380 in pre-market trading. Exela Technologies recently reported expansion of relationship with Mastercard in Europe.
• Vir Biotechnology, Inc. (NASDAQ:VIR) rose 5.6% to $42.23 in pre-market trading. The U.S. recently agreed to buy 600,000 more doses of GlaxoSmithKline and Vir Biotechnology’s COVID-19 antibody therapy for an undisclosed sum.
• Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) rose 4.4% to $138.00 in pre-market trading after the company released results for its fourth quarter on Thursday. The world’s largest chipmaker said its profit surged 16.4% to $5.98 billion, helped by rising demand for semiconductors.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• electroCore, Inc. (NASDAQ:ECOR) shares fell 10.1% to $0.7910 in pre-market trading. electroCore shares jumped 64% on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for PTSD treatment.
• Fangdd Network Group Ltd. (NASDAQ:DUO) fell 9.9% to $0.3740 in pre-market trading after surging 12% on Wednesday.
• Vaxxinity, Inc. (NASDAQ:VAXX) shares fell 8.5% to $6.92 in pre-market trading. Vaxxinity shares jumped 30% on Wednesday after the company announced the first Parkinson's disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312..
• Hillstream BioPharma, Inc. (NASDAQ:HILS) shares fell 8.4% to $3.18 in pre-market trading following a 13% decline on Wednesday.
• Vaxcyte, Inc. (NASDAQ:PCVX) fell 8.1% to $20.23 in pre-market trading after the company reported pricing of $100 million public offering.
• NEXGEL, Inc. (NASDAQ:NXGL) fell 5.7% to $3.09 in pre-market trading. NexGel shares gained around 12% on Wednesday after the company announced the launch of the MEDAGEL ClearComfort hydrogel patch.
• Jaguar Health, Inc. (NASDAQ:JAGX) fell 5.6% to $0.9628 in pre-market trading after gaining around 10% on Wednesday.
• Fathom Digital Manufacturing Corporation (NYSE:FATH) shares fell 5.2% to $6.49 in pre-market trading after jumping 29% on Wednesday.

Posted In: ADGI BTCS DUO ECOR EVFM FATH GRUB HILS JAGX KBH LGHL NXGL PBYI PCVX RNW TSM VAXX VIR VOLT XELA